{"id":6077,"date":"2025-10-16T10:16:23","date_gmt":"2025-10-16T01:16:23","guid":{"rendered":"https:\/\/cm-plus.co.jp\/en\/?p=6077"},"modified":"2025-10-16T10:58:50","modified_gmt":"2025-10-16T01:58:50","slug":"2025_1016","status":"publish","type":"post","link":"https:\/\/cm-plus.co.jp\/en\/news\/other\/2025_1016\/","title":{"rendered":"Strategic Partnership MOU signed with Taiwanese Companies, MetaTech AP and Locus Cell"},"content":{"rendered":"

CM Plus Singapore Pte. Ltd. and CM Plus Corporation (collectively, “CM Plus”) are pleased to announce the signing of a Memorandum of Understanding (MOU) with MetaTech AP Inc. (“MetaTech AP”, \u4e09\u9867\u80a1\u4efd\u6709\u9650\u516c\u53f8), a Taiwanese biotechnology company, and its subsidiary, Locus Cell Co., Ltd. (“Locus Cell”, \u6a02\u8fe6\u518d\u751f\u79d1\u6280\u80a1\u4efd\u6709\u9650\u516c\u53f8).\u00a0 The MOU establishes a framework for cooperation in the business areas of biologics, regenerative medicine, cell and gene therapy, and AI\/DX, covering both Taiwan and international markets, including Japan.
\n\"\"<\/p>\n

The MOU signing ceremony was held in the presence of Mr. Tsai Ming-Yaw, Deputy Representative of the Taipei Economic and Cultural Representative Office in Japan (Taiwan Representative Office).
\n\"\"
\nThe Signing Ceremony (From left: Mr. Jiunn-Rong Chiou, Chairman of Locus Cell; Mr. Tsunehiro Togashi, Group CEO of CM Plus Singapore; Mr. Alex Chen, Vice Chairman of MetaTech AP; Mr. Satoshi Sueko, President of CM Plus Corporation; Mr. Tsai Ming-Yaw, Deputy Representative of Taiwan Representative Office)<\/p>\n

 <\/p>\n

New Momentum for Taiwan’s Biotech Industry<\/h3>\n

In recent years, advanced modalities such as biopharmaceuticals and regenerative medicine products have been driving high growth in the pharmaceutical industry.\u00a0 Within this international supply chain, Taiwan is rapidly increasing its presence as a new hub for regenerative medicine in the Asia-Pacific region.\u00a0 While Taiwan has traditionally been recognized for its Contract Manufacturing (CMO) capabilities utilizing high-level manufacturing technologies, recent government legal reforms and industry promotion measures have transformed it from a mere manufacturing base into a critical gateway for Asian market strategies, including international partnerships, clinical trials, and market entry.<\/p>\n

 <\/p>\n

Overview of the Partnership<\/h3>\n

MetaTech AP was founded in 1998 as an electronic component distributor and later entered the medical field, including regenerative medicine.\u00a0 The company has accumulated manufacturing data from its past experiences in a database and is collaborating with academic research institutions to develop AI algorithms.\u00a0 By introducing the brain of smart manufacturing into cell production, the company aims to overcome challenges such as scaling production and quality control, making cell therapy more accessible.\u00a0 In 2021, MetaTech AP established Locus Cell, a joint venture with leading companies for the manufacture and sale of cells for regenerative medicine.<\/p>\n

Locus Cell, a CDMO (Contract Development and Manufacturing Organization) for regenerative medicine, is currently pursuing clinical manufacturing process certification from the US FDA and aims to acquire PMDA (Japan’s Pharmaceutical and Medical Devices Agency) certification in the future.\u00a0 By elevating manufacturing quality and regulatory compliance to the highest international standards, Locus Cell is reinforcing its business expansion into the Japanese and broader Asian markets.<\/p>\n

This partnership is expected to accelerate the development of a secure, reliable, and high-quality manufacturing system for MetaTech AP and Locus Cell in the regenerative medicine industry by integrating CM Plus’s expertise in production facility construction and regulatory compliance.<\/p>\n

Furthermore, the companies plan to establish a GMP AI ecosystem spanning Japan and Taiwan using various digital technologies, including MetaTech AP’s “Neo-Katana”, and CM Plus’s “pharmo.AI” AI solution and “CORRESSA”* project collaboration platform.<\/p>\n

Mr. Tsai Ming-Yaw, Deputy Representative of the Taiwan Representative Office, who attended the signing ceremony, expressed his expectations: “In a rapidly changing global industrial environment, smart manufacturing is key to enhancing competitiveness and innovation.\u00a0 This collaboration brings together the expertise of both parties in technology development, process optimization, and digital transformation.\u00a0 I am confident that it will generate strong synergies in areas like smart factories, automated production, and AI applications, bringing new vitality to the industry.”<\/p>\n

 <\/p>\n

* About “Neo-Katana”
\nNeo-Katana is a next-generation digital solution designed to streamline GMP documentation and compliance processes.\u00a0 By integrating AI-assisted authoring and automated version control, the system helps biopharma manufacturers reduce human error, enhance regulatory alignment, and accelerate document approval cycles.<\/p>\n

\n

About MetaTech AP<\/h3>\n

MetaTech (AP) Inc., \u4e09\u9867\u80a1\u4efd\u6709\u9650\u516c\u53f8, founded in 1998 and listed in Taiwan since 2004, operates across electronics and regenerative medicine.\u00a0 With patented M-Cell technology and AI-driven innovation, we lead in cell therapies for cartilage, skin, and organ repair.\u00a0 Headquartered in Taiwan, MetaTech serves markets across Asia with a vision to fuse tech and biotech for a healthier future.<\/p>\n

Open the corporate site of MetaTech AP (https:\/\/www.metatech.com.tw\/ja\/) in a new tab<\/a><\/p>\n<\/div>\n

\n

About Locus Cell<\/h3>\n

LOCUS CELL CO., LTD, \u6a02\u8fe6\u518d\u751f\u79d1\u6280\u80a1\u4efd\u6709\u9650\u516c\u53f8, will build a PIC\/S GMP-compliant cell facility in Hsinchu Biomedical Science Park, focusing on CDMO services for cellular products. The company will introduce advanced cell therapy products and technology resources from abroad and cooperate with Taiwan’s rich medical clinical resources to create the largest cell therapy facility in Taiwan.<\/p>\n

Open the corporate site of Locus Cell (https:\/\/www.locus-cell.com\/) in a new tab<\/a><\/p>\n<\/div>\n

 <\/p>\n

\n

Service<\/h2>\n